Acknowledgements
J. Donnelly
The study was funded by Astellas Pharma Inc. The authors thank the patients, caregivers, investigators and site staff who participated in this study. We thank J. Raizer; study managers J. Donnelly, S. Koshy Hunt, A. Shrivastava and C. Muench; and steering committee members S. Kim and S. Klempner. We thank S. Moran, C. Beckman, J. McDonald, S. Arora, J. Pugh, M. Kouzova, L. Pang and the CLDN18 project team at Roche Tissue Diagnostics for their collaboration in assay development, clinical trial implementation and technical review of the manuscript. We thank A. Ferguson from Oxford PharmaGenesis, Inc., who provided medical writing support that was funded by Astellas Pharma Inc.